Replies to post #224736 on Biotech Values

[DewDiligence]

PFE—FDA approves Bavencio/Inlyta combination in first-line RCC:

https://finance.yahoo.com/news/fda-approves-bavencio-avelumab-plus-002500175.html

The FDA recently approved Keytruda/Inlyta in the same indication (#msg-148355182), so it’s unclear whether Bavencio/Inlyta will get much commercial uptake.